» Articles » PMID: 23439554

From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2013 Feb 27
PMID 23439554
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system that develops in genetically susceptible individuals, probably triggered by common environmental factors. Human leukocyte antigen (HLA) loci were early shown to confer the strongest genetic associations in MS. Now, more than 50 non-HLA MS susceptibility loci are identified, of which the majority are located in immune-regulatory genes. Single nucleotide polymorphisms (SNPs) in the C-type lectin-like domain family 16A (CLEC16A) gene were among the first non-HLA genetic variants that were confirmed to be associated with MS. Fine-mapping has indicated a primary association in MS and also other autoimmune diseases to intronic CLEC16A SNPs. Here, we review the identification of MS susceptibility variants in the CLEC16A gene region, functional studies of the CLEC16A molecule and the recent progress in understanding the implications thereof for MS development. This may serve as an example of the importance for further molecular investigation of the loci identified in genetic studies, with the aim to translate this knowledge into the clinic.

Citing Articles

CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model.

Kadowaki A, Wheeler M, Li Z, Andersen B, Lee H, Illouz T Nat Neurosci. 2025; 28(3):470-486.

PMID: 40033124 DOI: 10.1038/s41593-025-01875-9.


Is DEXI a Multiple Sclerosis Susceptibility Gene?.

Eriksson A, Emini N, Harbo H, Berge T Int J Mol Sci. 2025; 26(3).

PMID: 39940946 PMC: 11818924. DOI: 10.3390/ijms26031175.


Trio-based exome sequencing and high-resolution HLA typing in families of patients with autoimmune adrenal insufficiency and autoimmune polyglandular syndrome.

Buianova A, Yukina M, Cheranev V, Suchalko O, Shmitko A, Samitova A PLoS One. 2024; 19(10):e0312335.

PMID: 39423205 PMC: 11488712. DOI: 10.1371/journal.pone.0312335.


-An Emerging Master Regulator of Autoimmunity and Neurodegeneration.

Pandey R, Bakay M, Hakonarson H Int J Mol Sci. 2023; 24(9).

PMID: 37175930 PMC: 10179542. DOI: 10.3390/ijms24098224.


A gene regulatory network approach harmonizes genetic and epigenetic signals and reveals repurposable drug candidates for multiple sclerosis.

Manuel A, Dai Y, Jia P, Freeman L, Zhao Z Hum Mol Genet. 2022; 32(6):998-1009.

PMID: 36282535 PMC: 9991005. DOI: 10.1093/hmg/ddac265.


References
1.
. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41(7):824-8. DOI: 10.1038/ng.396. View

2.
Edgar A, Birks E, Yacoub M, Polak J . Cloning of dexamethasone-induced transcript: a novel glucocorticoid-induced gene that is upregulated in emphysema. Am J Respir Cell Mol Biol. 2001; 25(1):119-24. DOI: 10.1165/ajrcmb.25.1.4417. View

3.
Hehnly H, Chen C, Powers C, Liu H, Doxsey S . The centrosome regulates the Rab11- dependent recycling endosome pathway at appendages of the mother centriole. Curr Biol. 2012; 22(20):1944-50. PMC: 3917512. DOI: 10.1016/j.cub.2012.08.022. View

4.
Giovannoni G, Southam E, Waubant E . Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence. Mult Scler. 2012; 18(7):932-46. DOI: 10.1177/1352458511433302. View

5.
Davison L, Cooper J, Cope N, Wilson N, Smyth D, Howson J . Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum Mol Genet. 2011; 21(2):322-33. PMC: 3276289. DOI: 10.1093/hmg/ddr468. View